- Home
- OXSQ vs NVCT Comparison
OXSQ vs NVCT Comparison
Compare OXSQ & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXSQ
- NVCT
- Stock Information
- Founded
- OXSQ 2003
- NVCT 2020
- Country
- OXSQ United States
- NVCT United States
- Employees
- OXSQ N/A
- NVCT N/A
- Industry
- OXSQ Blank Checks
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- OXSQ Finance
- NVCT Health Care
- Exchange
- OXSQ Nasdaq
- NVCT Nasdaq
- Market Cap
- OXSQ 190.1M
- NVCT 170.3M
- IPO Year
- OXSQ N/A
- NVCT 2022
- Fundamental
- Price
- OXSQ $2.60
- NVCT $9.77
- Analyst Decision
- OXSQ
- NVCT Strong Buy
- Analyst Count
- OXSQ 0
- NVCT 2
- Target Price
- OXSQ N/A
- NVCT $15.00
- AVG Volume (30 Days)
- OXSQ 446.4K
- NVCT 128.5K
- Earning Date
- OXSQ 05-01-2025
- NVCT 05-06-2025
- Dividend Yield
- OXSQ 16.09%
- NVCT N/A
- EPS Growth
- OXSQ N/A
- NVCT N/A
- EPS
- OXSQ 0.09
- NVCT N/A
- Revenue
- OXSQ $42,683,205.00
- NVCT N/A
- Revenue This Year
- OXSQ $8.73
- NVCT N/A
- Revenue Next Year
- OXSQ N/A
- NVCT N/A
- P/E Ratio
- OXSQ $28.17
- NVCT N/A
- Revenue Growth
- OXSQ N/A
- NVCT N/A
- 52 Week Low
- OXSQ $2.40
- NVCT $4.44
- 52 Week High
- OXSQ $3.29
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- OXSQ 38.23
- NVCT 60.31
- Support Level
- OXSQ $2.56
- NVCT $8.45
- Resistance Level
- OXSQ $2.61
- NVCT $10.67
- Average True Range (ATR)
- OXSQ 0.05
- NVCT 0.99
- MACD
- OXSQ -0.01
- NVCT 0.08
- Stochastic Oscillator
- OXSQ 38.64
- NVCT 72.98
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing, and Diversified Insurance.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.